Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Revenue of Fagron NV (FAGR.BR)
Revenue in 2023 (TTM): $804.89 M
According to Fagron NV's latest financial reports the company's current revenue (TTM) is $804.89 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Fagron NV
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $804.89 M | $164.62 M | $149.74 M | $89.08 M | $74.42 M |
| 2022 | $721.43 M | $301.88 M | $143.06 M | $92.59 M | $73.43 M |
| 2021 | $605.32 M | $261.09 M | $122.37 M | $81.04 M | $64.35 M |
| 2020 | $586.5 M | $260.28 M | $121.84 M | $77.76 M | $62.87 M |
| 2019 | $564.06 M | $253.19 M | $117.84 M | $73.72 M | $58.74 M |
| 2018 | $497.58 M | $219.72 M | $91.95 M | $57.85 M | $44.82 M |
| 2017 | $460.93 M | $199.76 M | $97.46 M | $59.04 M | $49.22 M |
| 2016 | $445 M | $194.56 M | $52.24 M | $-6,713,450 | $-21,691,070 |
| 2015 | $498.97 M | $231.95 M | $44.65 M | $-206,054,612 | $-213,437,931 |
| 2014 | $471.6 M | $223.8 M | $116.22 M | $73.69 M | $17.12 M |
| 2013 | $407.32 M | $180.48 M | $75.95 M | $55.47 M | $-33,864,737 |
| 2012 | $577.06 M | $198.61 M | $69.24 M | $45.5 M | $46.32 M |
| 2011 | $519.36 M | $175.32 M | $62.91 M | $39.11 M | $29.69 M |
| 2010 | $447.34 M | $447.34 M | $51.86 M | $31.71 M | $23.71 M |
| 2009 | $412.8 M | $412.8 M | $45.45 M | $24.38 M | $20.72 M |
| 2008 | $373.97 M | $373.97 M | $41.99 M | $18.97 M | $15.72 M |
| 2007 | $321.08 M | $321.08 M | $39.31 M | $20.51 M | $17.15 M |
| 2006 | $292.18 M | $95.87 M | $28.45 M | $15.41 M | $12.79 M |
| 2005 | $298.8 M | $94.12 M | $35.03 M | $20.89 M | $15.89 M |
| 2004 | $298.84 M | $89.22 M | $32.61 M | $21.78 M | $14.56 M |